Fortress Biotech FBIOP
NASDAQ FBIOP
$18.30 +0.03 (+0.16%)
As of: Aug 21, 2026 · 3:33 PM EDT

Fortress Biotech, Inc. (FBIOP) Short term Debt (2017 - 2019)

Fortress Biotech (FBIOP) posted quarterly Short term Debt of $16000.0 for Q1 2019, down 87.1% year-over-year from $124000.0 in Q1 2018, and down 89.26% quarter-over-quarter from $149000.0 in Q4 2018.

Fortress Biotech, Inc. (FBIOP) Short term Debt (2017 - 2019) Analysis & Trends

Fortress Biotech's Short term Debt history runs 3 years deep, the most recent figure standing at $16000.0 for Q1 2019.

  • In Q1 2019, Short term Debt fell 87.1% year-over-year to $16000.0; the TTM figure through Mar 2019 stood at $16000.0 (down 87.1% YoY), while the FY2018 annual figure was $149000.0, down 32.88% from the prior year.
  • Short term Debt for Q1 2019 stood at $16000.0, down from $149000.0 in the prior quarter.
  • The five-year high for Short term Debt was $623000.0 in Q1 2017, with the low at $16000.0 in Q1 2019.
  • The 3-year median for Short term Debt is $124000.0 (2018), against an average of $169555.6.
  • The sharpest annual moves came in 2018 and 2019: Short term Debt surged 73.86% in 2018, then tumbled 87.1% in 2019.
  • Fortress Biotech's Short term Debt stood at $222000.0 in 2017, then sank by 32.88% to $149000.0 in 2018, then plunged by 89.26% to $16000.0 in 2019.
  • Business Quant data shows FBIOP's Short term Debt at $16000.0 in Q1 2019, $149000.0 in Q4 2018, and $153000.0 in Q3 2018.

Peer Comparison

Historic Data

Download Data
DateValue
Mar 31, 2019 16,000.00
Dec 31, 2018 149,000.00
Sep 30, 2018 153,000.00
Jun 30, 2018 73,000.00
Mar 31, 2018 124,000.00
Dec 31, 2017 222,000.00
Sep 30, 2017 88,000.00
Jun 30, 2017 78,000.00
Mar 31, 2017 623,000.00